Patent · US Active

Anti-CD79b antibodies and methods of use

US9975949B2 · kind B2 · utility

11Cited by
9References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 2015
Grant dateMay 22, 2018
Priority date—
Expiry dateDec 4, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-CD79b antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.